Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation: a cost-effectiveness analysis

Objectives - Colorectal cancers (CRC) are among the world's most prevailing cancer entities. In a third of all cases, the patients have already developed distant metastases - mainly in the liver - at the time of detection. Colorectal liver metastases (CRLM) can be treated by surgical resection...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schnitzer, Moritz Ludwig (VerfasserIn) , Buchner, Janine (VerfasserIn) , Biechele, Gloria (VerfasserIn) , Grawe, Freba (VerfasserIn) , Ingenerf, Maria (VerfasserIn) , Münchhausen, Niklas, Freiherr von (VerfasserIn) , Kaiser, Clemens G. (VerfasserIn) , Kunz, Wolfgang G. (VerfasserIn) , Froelich, Matthias F. (VerfasserIn) , Schmid-Tannwald, Christine (VerfasserIn) , Rübenthaler, Johannes (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 2023
In: European journal of radiology
Year: 2023, Jahrgang: 163, Pages: 1-11
ISSN:1872-7727
DOI:10.1016/j.ejrad.2023.110803
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejrad.2023.110803
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0720048X23001171
Volltext
Verfasserangaben:Moritz L. Schnitzer, Janine Buchner, Gloria Biechele, Freba Grawe, Maria Ingenerf, Niklas von Münchhausen, Clemens G. Kaiser, Wolfgang G. Kunz, Matthias F. Froelich, Christine Schmid-Tannwald, Johannes Rübenthaler

MARC

LEADER 00000caa a2200000 c 4500
001 1898185964
003 DE-627
005 20241205161616.0
007 cr uuu---uuuuu
008 240808s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejrad.2023.110803  |2 doi 
035 |a (DE-627)1898185964 
035 |a (DE-599)KXP1898185964 
035 |a (OCoLC)1475307002 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schnitzer, Moritz Ludwig  |e VerfasserIn  |0 (DE-588)1236365828  |0 (DE-627)1761723464  |4 aut 
245 1 0 |a Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation  |b a cost-effectiveness analysis  |c Moritz L. Schnitzer, Janine Buchner, Gloria Biechele, Freba Grawe, Maria Ingenerf, Niklas von Münchhausen, Clemens G. Kaiser, Wolfgang G. Kunz, Matthias F. Froelich, Christine Schmid-Tannwald, Johannes Rübenthaler 
264 1 |c June 2023 
300 |b Illustrationen 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 30. März 2023, Artikelversion: 31. März 2023 
500 |a Gesehen am 08.08.2024 
520 |a Objectives - Colorectal cancers (CRC) are among the world's most prevailing cancer entities. In a third of all cases, the patients have already developed distant metastases - mainly in the liver - at the time of detection. Colorectal liver metastases (CRLM) can be treated by surgical resection or, as is possible in most cases, by percutaneous ablation. For selecting the liver metastases eligible for radiofrequency ablation (RFA) or microwave ablation (MWA), the common imaging modalities are magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT), and contrast-enhanced computed tomography (CE-CT). This study aims to evaluate those imaging modalities for selecting liver lesions eligible for ablation according to their long-term cost-effectiveness. - Materials and methods - A Markov model was applied, calculating quality-adjusted life years (QALYs) and accumulative costs for every diagnostic strategy, according to predefined input parameters obtained from published research. Further, sensitivity analyses were executed to prove the certainty of the calculations by running Monte-Carlo simulations with 30,000 reiterations. The Willingness-to-pay (WTP) is at $ 100,000. All calculations are based on the U.S. healthcare system. - Results - CE-CT caused cumulative costs of $ 31,940.98 and 8,99 QALYs, whereas MRI caused $ 32,070.83 and 9,01 QALYs. PET/CT caused cumulative costs of $ 33,013.21 and 8,99 QALYs. - Conclusion - In conclusion, according to our analysis, MRI is the most cost-effective strategy for detecting liver metastases eligible for ablation and therefore should be seen as the gold standard. 
650 4 |a Colorectal liver metastasis 
650 4 |a Cost-effectiveness 
650 4 |a Liver ablation 
650 4 |a MRI 
650 4 |a PET/CT 
700 1 |a Buchner, Janine  |e VerfasserIn  |4 aut 
700 1 |a Biechele, Gloria  |e VerfasserIn  |4 aut 
700 1 |a Grawe, Freba  |e VerfasserIn  |4 aut 
700 1 |a Ingenerf, Maria  |e VerfasserIn  |4 aut 
700 1 |a Münchhausen, Niklas  |c Freiherr von  |d 1984-  |e VerfasserIn  |0 (DE-588)1232354643  |0 (DE-627)1756272611  |4 aut 
700 1 |a Kaiser, Clemens G.  |d 1978-  |e VerfasserIn  |0 (DE-588)143154621  |0 (DE-627)704405733  |0 (DE-576)335371981  |4 aut 
700 1 |a Kunz, Wolfgang G.  |e VerfasserIn  |4 aut 
700 1 |a Froelich, Matthias F.  |d 1991-  |e VerfasserIn  |0 (DE-588)1170833756  |0 (DE-627)1040131557  |0 (DE-576)512678359  |4 aut 
700 1 |a Schmid-Tannwald, Christine  |e VerfasserIn  |4 aut 
700 1 |a Rübenthaler, Johannes  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of radiology  |d Amsterdam [u.a.] : Elsevier Science, 1990  |g 163(2023), Artikel-ID 110803, Seite 1-11  |h Online-Ressource  |w (DE-627)32044483X  |w (DE-600)2005350-2  |w (DE-576)099718138  |x 1872-7727  |7 nnas  |a Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation a cost-effectiveness analysis 
773 1 8 |g volume:163  |g year:2023  |g elocationid:110803  |g pages:1-11  |g extent:11  |a Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation a cost-effectiveness analysis 
856 4 0 |u https://doi.org/10.1016/j.ejrad.2023.110803  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0720048X23001171  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240808 
993 |a Article 
994 |a 2023 
998 |g 1170833756  |a Froelich, Matthias F.  |m 1170833756:Froelich, Matthias F.  |d 60000  |d 62900  |d 60000  |e 60000PF1170833756  |e 62900PF1170833756  |e 60000PF1170833756  |k 0/60000/  |k 1/60000/62900/  |k 0/60000/  |p 9 
998 |g 143154621  |a Kaiser, Clemens G.  |m 143154621:Kaiser, Clemens G.  |d 60000  |d 62900  |e 60000PK143154621  |e 62900PK143154621  |k 0/60000/  |k 1/60000/62900/  |p 7 
998 |g 1232354643  |a Münchhausen, Niklas  |m 1232354643:Münchhausen, Niklas  |d 60000  |e 60000PM1232354643  |k 0/60000/  |p 6 
999 |a KXP-PPN1898185964  |e 4563854883 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1898185964","id":{"doi":["10.1016/j.ejrad.2023.110803"],"eki":["1898185964"]},"title":[{"title":"Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation","title_sort":"Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation","subtitle":"a cost-effectiveness analysis"}],"note":["Online verfügbar: 30. März 2023, Artikelversion: 31. März 2023","Gesehen am 08.08.2024"],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"June 2023"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"display":"Schnitzer, Moritz Ludwig","role":"aut","given":"Moritz Ludwig","roleDisplay":"VerfasserIn","family":"Schnitzer"},{"family":"Buchner","roleDisplay":"VerfasserIn","role":"aut","display":"Buchner, Janine","given":"Janine"},{"display":"Biechele, Gloria","role":"aut","given":"Gloria","roleDisplay":"VerfasserIn","family":"Biechele"},{"family":"Grawe","roleDisplay":"VerfasserIn","role":"aut","display":"Grawe, Freba","given":"Freba"},{"given":"Maria","display":"Ingenerf, Maria","role":"aut","roleDisplay":"VerfasserIn","family":"Ingenerf"},{"family":"Münchhausen","roleDisplay":"VerfasserIn","given":"Niklas","role":"aut","display":"Münchhausen, Niklas"},{"role":"aut","display":"Kaiser, Clemens G.","given":"Clemens G.","roleDisplay":"VerfasserIn","family":"Kaiser"},{"display":"Kunz, Wolfgang G.","role":"aut","given":"Wolfgang G.","family":"Kunz","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Froelich","role":"aut","display":"Froelich, Matthias F.","given":"Matthias F."},{"family":"Schmid-Tannwald","roleDisplay":"VerfasserIn","given":"Christine","display":"Schmid-Tannwald, Christine","role":"aut"},{"family":"Rübenthaler","roleDisplay":"VerfasserIn","given":"Johannes","display":"Rübenthaler, Johannes","role":"aut"}],"physDesc":[{"noteIll":"Illustrationen","extent":"11 S."}],"name":{"displayForm":["Moritz L. Schnitzer, Janine Buchner, Gloria Biechele, Freba Grawe, Maria Ingenerf, Niklas von Münchhausen, Clemens G. Kaiser, Wolfgang G. Kunz, Matthias F. Froelich, Christine Schmid-Tannwald, Johannes Rübenthaler"]},"relHost":[{"recId":"32044483X","pubHistory":["Nachgewiesen 10.1990 -"],"titleAlt":[{"title":"EJR"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"1990","publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1990-","publisher":"Elsevier Science"}],"part":{"extent":"11","year":"2023","pages":"1-11","text":"163(2023), Artikel-ID 110803, Seite 1-11","volume":"163"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation a cost-effectiveness analysisEuropean journal of radiology","note":["Gesehen am 05.02.20"],"title":[{"subtitle":"EJR","title_sort":"European journal of radiology","title":"European journal of radiology"}],"id":{"issn":["1872-7727"],"zdb":["2005350-2"],"eki":["32044483X"]}}]} 
SRT |a SCHNITZERMECONOMICEV2023